Literature DB >> 2316015

Significance of arterial ketone body ratio measurement in human liver transplantation.

Y Taki1, G Gubernatis, Y Yamaoka, M Oellerich, Y Yamamoto, B Ringe, R Okamoto, H Bunzendahl, M Beneking, M Burdelski.   

Abstract

Arterial ketone body ratio (KBR), which reflects the NAD+/NADH ratio of hepatic mitochondria, was measured sequentially in 39 liver transplantations. In 22 cases, KBR was increased to above 0.7 within 6 hr after reperfusion (group A). In 11 cases, restoration of KBR was delayed until the first postoperative day (group B) and in 6 cases, KBR failed to recover (group C). The patients in group A survived liver transplantation without complications. By contrast, morbidity and mortality were significantly higher in groups B and C. In 2 cases in group C, the livers were clinically diagnosed as initially nonfunctioning grafts and the patients underwent retransplantation. Another two died of hepatic failure soon after the operation. It is suggested that delayed recovery of KBR is an early indicator of metabolic overload in the liver allograft, and that a delay exceeding 24 hr may imply the need for retransplantation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316015     DOI: 10.1097/00007890-199003000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Changes in plasma concentrations of free amino acids during and after the anhepaic period.

Authors:  K Irita; H Okamoto; H Inoue; M Umeki; S Inaba; S Taniguchi; Y Sakaguchi; K Mazuda; M Yamakawa; J Yoshitake; S Takahashi
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

2.  Pretransplant assessment of human liver grafts by plasma lecithin: cholesterol acyltransferase (LCAT) activity in multiple organ donors.

Authors:  M Shimada; K Yanaga; H Higashi; L Makowka; S Kakizoe; T E Starzl
Journal:  Transpl Int       Date:  1992-03       Impact factor: 3.782

3.  Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.

Authors:  S Takaya; H Doyle; S Todo; W Irish; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-04       Impact factor: 1.066

4.  Functional deterioration of the liver by elevated inferior vena cava pressure: a proposed upper safety limit of pressure for maintaining liver viability in dogs.

Authors:  H Higashiyama; M Yamaguchi; K Kumada; H Sasaki; T Yamaguchi; K Ozawa
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

5.  Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?

Authors:  H R Doyle; I R Marino; N Jabbour; G Zetti; J McMichael; S Mitchell; J Fung; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

6.  Predicting the viability of grafted livers in rats through a rapid and sensitive metabolic indicator assessed by 31P-NMR spectroscopy.

Authors:  M Yang; H Shimada; T Kobayashi; S Niimoto; G Nakagawara
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors.

Authors:  K Ozawa; S Uemoto; K Tanaka; K Kumada; Y Yamaoka; N Kobayashi; T Inamoto; Y Shimahara; K Mori; K Honda
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

8.  Significance of the hepatic mitochondrial redox state in the development of posttraumatic jaundice.

Authors:  T Nakatani; Y Endoh; K Kobayashi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Apparent normobasemia as a negative prognostic sign immediately after hepatectomy.

Authors:  Y Wada; K Mori; M Sugano; T Fujii; Y Shimahara; Y Yamaoka; K Ozawa
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

10.  The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation.

Authors:  K Asonuma; S Takaya; R Selby; R Okamoto; Y Yamamoto; T Yokoyama; S Todo; K Ozawa; T E Starzl
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.